Attain Stability™ Quad Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 471 participants.

Also called NCT03099655

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 471 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03099655
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Germany, Hong Kong SAR China, Italy, Malaysia, Netherlands, Norway, Spain, Sweden (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03099655. Allocation not applicable; no masking; primary purpose treatment. Start 2017-07-07 (actual); primary completion 2018-08-02 (actual). Results posted on 2020-01-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Attain Stability™ Quad Clinical Study
Condition
Heart Failure
Intervention (Device)
Attain Stability Quad Left Ventricular Pacing Lead
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct03099655
Content hash
bc31e6032778e2e75c5b74a6040d0d183d8be33b1f14f5ea087b736a0400a1ef